In a nutshell
Labi Saúde is a clinical analysis testing laboratory focused on offering convenience and the best prices in the market. They want to expand access to quality diagnostics by creating a smart way to run tests. That is why they specialize in lab tests and reduce all the bureaucracy to offer you quality exams at fair prices.
DIF I
BR
23.5558° S, 46.6396° W
(3) Good Health and Well-Being, (10) Reduced Inequalities
n/a
KPI's
2024 consolidated metrics
Exams
11.2M
(22% YoY)
Total Unique Clients
1M
(17% YoY)
% price discount compared to market average
40%
(flat YoY)
NPS
78
(-7% YoY)
% of clients without healthcare plan
69%
(-12%YoY)
Positive Notes
In 2025, Labi Saúde consolidated home-based care (dehospitalization) as its primary growth engine, expanding operations to more than 160 cities across Brazil. By shifting appropriate treatments from hospital settings to patients’ homes, Labi delivers high-quality care at materially lower cost—contributing directly to a more sustainable, value-based healthcare system. This model reduces waste, reallocates resources more efficiently, and alleviates pressure on overcrowded hospitals and emergency services.
The company also expanded access through partnerships with 94 health insurance operators, reinforcing its national footprint. Importantly, Labi achieved positive EBITDA and advanced operational cash generation, demonstrating that large-scale impact can be financially sustainable and not dependent on ongoing subsidies.
The main challenge in 2025 was financing accelerated growth. As operations expanded faster than planned, working capital needs increased—particularly due to payer reimbursement cycles. Managing this capital intensity while sustaining rapid expansion will be central to maintaining both financial resilience and long-term impact.